Clinical data in Swiss pharma companies is typically trapped in dozens of legacy systems, electronic health records, trial databases, and safety platforms. This fragmentation slows research, limits real-time insights, and creates compliance challenges under the EU AI Act. Leading Swiss life sciences organisations are now deploying sovereign agentic data activation systems that securely unlock and activate information across these silos in real time — delivering a unified, compliant view of clinical data while keeping every record fully resident on Swiss infrastructure.
- Secure activation of siloed clinical data without risky data migration
- Real-time, context-aware insights for researchers and clinicians
- Full EU AI Act compliance with built-in explainability and audit trails
- Sovereign deployment on Exoscale SKS guarantees complete data residency
- Research and clinical operations teams gain 3–5× faster access to unified data
The Clinical Data Silo Problem in Swiss Pharma
Most Swiss pharma companies still operate with fragmented clinical data spread across legacy EDC systems, pharmacovigilance databases, imaging repositories, and internal research archives. This fragmentation creates critical blind spots, slows down research decision-making, and increases regulatory risk when full traceability is required by auditors and health authorities.
The Sovereign Agentic Data Activation Solution
A new generation of sovereign multi-agent systems is addressing this challenge. These platforms use secure sovereign RAG combined with LangGraph orchestration to activate clinical data across silos without physically moving or duplicating it — delivering a unified, real-time clinical intelligence layer while maintaining strict access control and full regulatory compliance.
How the Multi-Agent System Works
Built with LangGraph orchestration, the solution coordinates specialised agents:
• Secure Data Discovery Agent – identifies and securely connects to distributed clinical data sources using sovereign RAG
• Activation & Enrichment Agent – unifies and contextualises clinical data in real time without data replication or migration
• Insight & Reasoning Agent – generates accurate, fully cited answers for complex clinical and research queries
• Compliance & Governance Agent – enforces EU AI Act requirements, consent policies, and end-to-end audit logging
The entire system operates with full traceability, strict access control, and zero sensitive data leaving Swiss jurisdiction.
Proven Results from Swiss Life Sciences Companies
Early deployments of sovereign clinical data activation systems have delivered measurable impact:
• Research teams gain immediate access to unified clinical intelligence
• Time-to-insight reduced by 60–80%
• Improved regulatory audit readiness through automated traceability
• Stronger collaboration across clinical, safety, and R&D functions
• Full EU AI Act compliance achieved by design
Why Sovereignty Is Non-Negotiable for Clinical Data Activation
Clinical trial data, patient records, and research outputs are among the most sensitive assets in life sciences. Foreign cloud-based AI systems introduce unacceptable risks around data residency, consent enforcement, and regulatory oversight.
Sovereign agentic platforms remove these risks by ensuring all data processing, reasoning, and orchestration remain fully within Swiss-controlled infrastructure — enabling scalable clinical intelligence without compromising compliance or patient trust.
